Marshall Wace’s Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock REVH Stock Holding History

Marshall Wace’s Portfolio REVH Stock Details REVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,260,399	Closed	-$22.2M	–	3801
2022 Q3	$22.2M	Buy	2,260,399 +401,191	+22%	+$3.94M	0.05%	426
2022 Q2	$18.1M	Buy	1,859,208 +1,750,017	+1,603%	+$17.1M	0.04%	512
2022 Q1	$1.07M	Hold	109,191	–	–	﹤0.01%	2425
2021 Q4	$1.06M	Buy	109,191 +51,491	+89%	+$503K	﹤0.01%	2444
2021 Q3	$561K	Buy	+57,700	New	+$562K	﹤0.01%	2328

Marshall Wace's REVH Position: Q4 2022 in Review

Marshall Wace sold out of Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) in Q4 2022, closing a stake of 2,260,399 shares — an estimated $22.2M sold.

Marshall Wace first reported a position in REVH in Q3 2021 and held it in 5 quarters. The position peaked at $22.2M in Q3 2022. 0 funds tracked by Wall St. Rank hold REVH as of Q4 2022.

Marshall Wace reported no remaining Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Marshall Wace sold 2,260,399 Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock shares in Q4 2022, an estimated $22.2M.
Marshall Wace first reported a position in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in Q3 2021 and held it in 5 quarters.
Marshall Wace's Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position peaked at $22.2M in Q3 2022.
0 funds tracked by Wall St. Rank held Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.